Fruit Fly Fights Human Disease
Posted on: Tuesday, 23 June 2009, 10:07 CDT
"By putting mutant genes from human patients into fruit flies, we've created the first ever fly model for this kind of neuromuscular disease," says Albena Jordanova. "Now we have the opportunity to unravel the molecular mechanism behind Charcot-Marie-Tooth, as well as to start looking for substances with therapeutic value."The breakthrough is the result of collaboration between VIB researchers working at the University of Antwerp and the Katholieke Universiteit Leuven, and appears in the Proceedings of the National Academy of Sciences (PNAS).
Charcot-Marie-Tooth is a hereditary disorder of the peripheral nervous system that affects 1 in 2,500 people worldwide. Patients suffer from progressive motor impairment, muscle wasting and weakness, sensory loss, and foot deformities . Affecting children and adults, the disease often starts with minor symptoms, gradually worsening over time. Presently CMT cannot be cured or prevented.
New chapter for an old gene
In previous research Albena Jordanova and Vincent Timmerman (VIB, University of Antwerp) discovered that CMT patients in families in Belgium, Bulgaria and the US showed three specific changes in one of the most ubiquitous genes in life: the YARS gene. YARS is responsible for the production of one of the oldest enzymes in the history of life (tyrosyl-tRNA synthetase), which is vital for the production of proteins. This was an entirely unexpected breakthrough. YARS had been considered a closed chapter in the biology textbooks. No one had suspected the relationship with specific variants of CMT until the revelation by Jordanova and her colleagues. These VIB findings open up an entirely new field of research.
Fruit flies with CMT symptoms
The VIB researchers at the University of Antwerp, in collaboration with Patrick Callaerts (VIB, K.U.Leuven) introduced four variants of the YARS gene into fruit flies. The normal variant, showed no difference in ordinary fruit flies. However, fruit flies with the mutant YARS genes, showed clear symptoms of CMT such as a reduced capacity to move, decreased functioning of the nerve cells and degeneration of the nerve endings.
---------
On The Net:
VIB (the Flanders Institute for Biotechnology)
Related Articles
- Hit NBC Universal Shows in Your Pocket
- Treatment Side Effects Involving Skin Hamper Quality of Life for Cancer Patients, New Survey Shows
- Charles Drew University Shows Largest Gains in Published Research Among Top 200 Universities With Federal Research Funding
- Novation Survey on Obese Patient Care Supplies Shows Nearly 50 Percent Increase in New Bariatric Supply Purchases As Obese Patient Admissions Continue to Rise
- Safety Analyses of Clinical Data for Bifeprunox in Patients With Schizophrenia Showed a Favorable Weight and Lipid Profile, Comparable With Placebo
- Safety Analyses of Clinical Data for Bifeprunox in Patients With Schizophrenia Showed a Favorable Weight and Lipid Profile, Similar to Placebo
- Local Students Show Off Works, Win Scholarships at University Show
- Just What the Patient Ordered: Trend Shows Some Willing to Pay Extra for Doctors on Demand
- HealthGrades Patient Safety Study Shows Increase in Hospital Incidents, Wide Gaps Among States and Hospitals
- Cell Phone Use in OR Could Improve Patient Safety, a Survey Shows
User Comments (0)

RSS Feeds